CSIMarket


Xtant Medical Holdings Inc   (XTNT)
Other Ticker:  
 

Xtant Medical Holdings Inc

XTNT's Fundamental analysis








Looking into Xtant Medical Holdings Inc growth rates, revenue grew by 68.26 % in III. Quarter 2023 from the same quarter a year ago. Ranking at No. 1966

Biotechnology & Pharmaceuticals industry recorded deterioration of revenues by -7.98 %

Xtant Medical Holdings Inc realized net income compared to net loss a year ago in III. Quarter 2023

More on XTNT's Growth


Xtant Medical Holdings Inc
current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.

Xtant Medical Holdings Inc PEG ratio is at -0.89 Xtant Medical Holdings Inc realized cash outflow of $ -0.07per share in trailing twelve-month period.
Company
98.12
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.87.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.63.


More on XTNT's Valuation
 
 Total Debt (Millions $) 17
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 5.54
 Tangible Book Value (Per Share $) 0.28

Xtant Medical Holdings Inc
current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.

Xtant Medical Holdings Inc PEG ratio is at -0.89 Xtant Medical Holdings Inc realized cash outflow of $ -0.07per share in trailing twelve-month period.
Company
98.12
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.87.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.63.

Xtant Medical Holdings Inc Price to Book Ratio is at 2.63 lower than Indusry Avg. of 826.38. and higher than S&P 500 Avg. of 0.01

More on XTNT's Valuation

  Market Capitalization (Millions $) 144
  Shares Outstanding (Millions) 136
  Employees -
  Revenues (TTM) (Millions $) 77
  Net Income (TTM) (Millions $) 3
  Cash Flow (TTM) (Millions $) -9
  Capital Exp. (TTM) (Millions $) -2
  Total Debt (Millions $) 17
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 5.54
  Tangible Book Value (Per Share $) 0.28

  Market Capitalization (Millions $) 144
  Shares Outstanding (Millions) 136
  Employees -
  Revenues (TTM) (Millions $) 77
  Net Income (TTM) (Millions $) 3
  Cash Flow (TTM) (Millions $) -9
  Capital Exp. (TTM) (Millions $) -2





  Ratio
   Capital Ratio (MRQ) 2.92
  Total Debt to Equity (MRQ) 0.31
  Tangible Leverage Ratio (MRQ) 0.99
  Asset Turnover Ratio (TTM) 1.1
  Inventory Turnover Ratio (TTM) 1.34





Xtant Medical Holdings Inc net profit margin of 37.93 % is currently ranking no. 4 in Biotechnology & Pharmaceuticals industry, ranking no. 34 in Healthcare sector and number 262 in S&P 500.

More on XTNT's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com